Leerink Reaffirms Neovasc (NVCN) at 'Outperform' Amid Boston Scientific Deal

Go back to Leerink Reaffirms Neovasc (NVCN) at 'Outperform' Amid Boston Scientific Deal
Boston Scientific (NYSE: BSX) Delayed: 50.37 +1.00 (2.03%)
Previous Close $49.37    52 Week High $24.79 
Open $49.22    52 Week Low $15.67 
Day High $50.90    P/E N/A 
Day Low $49.01    EPS $-0.09 
Volume 35,991,883       

(NASDAQ: NVCN) Delayed: 30.03 --0 (-0%)
Previous Close $30.03    52 Week High $5.04 
Open $4.36    52 Week Low $0.37 
Day High $30.03    P/E N/A 
Day Low $30.03    EPS $0.00 
Volume 350,983